Optimizing Risk Assessment Through cfDNA in Pancreatic Neuroendocrine Tumors for Clinical Evaluation: a Retrospective Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07817225

Title field or adapter rule

{'original_value': 'Optimizing Risk Assessment Through cfDNA in Pancreatic Neuroendocrine Tumors for Clinical Evaluation: a Retrospective Study', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:25.603483+00:00

Published At

2026-09-16T00:00:00+00:00

Record Updated At

2026-09-16

Source Retrieved At

2026-10-31T22:17:56.788771+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Pancreatic Neuroendocrine Tumor"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-09-16", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT07817225"

protocolSection.identificationModule.officialTitle

"Optimizing Risk Assessment Through cfDNA in Pancreatic Neuroendocrine Tumors for Clinical Evaluation: a Retrospective Study"

protocolSection.statusModule.overallStatus

"ACTIVE_NOT_RECRUITING"

protocolSection.designModule.phases

null

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Pancreatic Neuroendocrine Tumor (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['PanNET under active surveillance', 'histological aggressive PanNET', 'histological indolent PanNET'], 'description': 'Circulating-free DNA (cfDNA) will be extracted from plasma samples previously collected and currently stored at the San Raffaele Hospital (HSR) NETBank biobank. cfDNA profiling will be performed using methylome and nucleosome footprinting techniques. No therapeutic or experimental intervention will be performed.', 'name': 'cfDNA molecular profiling', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.